| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-421 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate |
1996-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d43bf32716af133abf736e15f7cde11b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_133ce45dedb49e7a99ced2f26805ea5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ae87ee119a0c589014412fc713c827d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78c8f27aac87380d56eee099f7d86089
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9be0e7a826278bee10666fe716ec6d88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e4f03cc13055751ae469a579fbff46b |
| publicationDate |
2006-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2212440-C |
| titleOfInvention |
Pharmaceutical preparations for tnf inhibition |
| abstract |
The use of the compounds of formula I (see formula I) for treating TNF-mediated diseases is described. |
| priorityDate |
1995-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |